San Jose, CA – According to filings with the U.S. Securities and Exchange Commission, Rani Therapeutics is raising $75,000,000.00 in new funding. Sources indicate as part of senior management Chairman and Chief Executive Officer, Mir Imran played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Rani Therapeutics

Rani Therapeutics has developed the RaniPill, a platform technology for the oral delivery of biologic drugs. Millions of patients with chronic conditions require biologic drugs that today can only be injected. Our mission is to improve the lives of millions of patients suffering from chronic conditions by replacing painful injections with an easy and pain free pill.

To learn more about Rani Therapeutics, visit http://www.ranitherapeutics.com/

Contact:
Mir Imran, Chairman and Chief Executive Officer
408-457-3700
https://www.linkedin.com/in/mirimran/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved